A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma
Open Access
- 31 August 2000
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (5) , 471-481
- https://doi.org/10.1038/sj.bmt.1702531
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 1997
- Improved Priming for Mobilization of and Optimal Timing for Harvest of Peripheral Blood Stem CellsJournal of Hematotherapy, 1996
- Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.The Journal of Experimental Medicine, 1996
- North American Multicenter Study on Flow Cytometric Enumeration of CD34+ Hematopoietic Stem CellsJournal of Hematotherapy, 1996
- Clinical applications of stem cell factorCurrent Opinion in Hematology, 1996
- Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cellsThe International Journal of Cell Cloning, 1996
- Optimization of Peripheral Blood Stem Cell MobilizationThe International Journal of Cell Cloning, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Complications of Peripheral Blood Stem Cell Harvesting: Review of 554 PBSC LeukapheresesJournal of Hematotherapy, 1995
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992